Research Highlight | Published:


68Ga-PSMA-11 PET enables accurate detection of recurrent disease

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Additional information

This article is modified from the original in Nat. Rev. Clin. Oncol. (


    Original article

    1. Fendler, W. P. et al. Assessment of 68Ga-PSMA-11 PET accuracy in localizing recurrent prostate cancer: a prospective single-arm clinical trial. JAMA Oncol. (2019)

    Further reading

    1. Maurer, T. et al. Current use of PSMA–PET in prostate cancer management. Nat. Rev. Urol. 13, 226–235 (2016)

    Download references

    Author information

    Correspondence to Conor A. Bradley.

    Rights and permissions

    Reprints and Permissions

    About this article